Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
http://FreeGames24-7.com Video Games? We Got Games! Free Unlimited PC Play! Start your One Month Free Trial Here. You're gonna love it or cancel with no cost or obligation.
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children’s Hospital of Philadelphia (CHOP) co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/chop/48124/
SIRO Clinpharm, a leading full service clinical research organization, unveiled its new brand identity on Friday. The new look affirms the recent transformation in the company’s business strategy.
“With the vast experience garnered over the past 16 years, SIRO was set to take a leap forward. With its customer centric leadership, we have built depth in various areas of competencies, leveraging our 4 pillars – people, processes, technologies and solutions,” said Dr. Gautam Daftary, founder and chairman, SIRO Clinpharm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58672-SIRO-Clinpharm-unveils-new-brand-identity
In this short video Martin Rogers Head of Litigation and Dispute Resolution in Asia for Clifford Chance, and General Editor of The Hong Kong White Book discusses the changes to evidence and trial procedure following the implementation of Civil Justice Reform in Hong Kong (2 April 2009).http://cjrblog.sweetandmaxwell.com.hk
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
Back by popular demand, the Recreational Boating & Fishing Foundation’s (RBFF) Take Me Fishing™ campaign is kicking off Catch A Boat 3.0, an online fishing tournament that includes a sweepstakes to win daily prizes or the grand prize boat, motor and trailer. Beginning November 29, 2010 at noon ET, boaters and anglers are invited to take part in TakeMeFishing.org’s interactive game for a chance to reel in the grand prize Stratos fishing boat, provided by the North American Fishing Club (NAFC). NAFC is also offering players a 30-day free trial membership, which includes a free issue of North American Fisherman.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/catchaboat/47487/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and haemodynamic monitoring, announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial. These data demonstrate that the study achieved its primary endpoint at one year, concluding that survival of patients treated with the Edwards SAPIEN transcatheter aortic valve was equivalent to those treated with surgical aortic valve replacement. The data were presented at the American College of Cardiology’s (ACC) 60th Annual Scientific Session & Expo in New Orleans, LA, USA.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/48895/
http://attorneydirectoryofamerica.com/phoenix-arizona-criminal_law_attorneys-attorney-directory.aspx Are you in need of a criminal law attorney in Phoenix? The criminal law firms of Phoenix listed at Attorney Directory of America have a successful track record of representing people throught the state of Arizona with a wide range of criminal issues. They represent people who are involved with criminal law issues, whether they've been personally involved or an associated entity. When it comes to criminal law, its important for you to find an attorney in Phoenix who knows how to deal with the prosecutors and prepare your case for trial should it progress to that point. Your should find a law office that is dedicated to using all of its legal skills and prowess, along with its many years of experience to assist you with this difficult time you are going through. If you have a criminal law issue, contact one of the firms at Attorney Directory of America.
PR Consulting at http://www.endustryinsider.com/prconsulting - Get an inside look at Mynewsdesk, a PR consultant and brand engagement platform used by 30,000+ companies around the world. The power of great Public Relations and brand engagement is big for your marketing strategy, and by choosing Mynewsdesk it can become great! 30-Day Free Trial On Any Account. No strings attached. No credit card required. You will never be charged for your first 30 days. And unless you tell us not to, your trial account will automatically revert to the Free subscription level. http://www.endustryinsider.com/prconsulting YouTube: http://www.youtube.com/watch?v=OCaR7KAblig
